ProS1

ProS1

ProS1 Overview

Molecule Name
Prostate-specific antigen
Synonyms
PROS, PS21, PS22, PS23, PS24, PS25, PSA, THPH5, THPH6
Drug Development Progress
Drugs in Clinical Trials2
Approved Drugs1
Highest Development StageApproved
Target Synonym
P-30 antigen,Semenogelase,APS,Prostate-specific antigen,PSA,Kallikrein Related Peptidase 3,Gamma-Seminoprotein,Kallikrein-3,Seminin,Kallikrein 3, (Prostate Specific Antigen),EC 3.4.21.77,KLK2A1,HK3,KLK3,EC 3.4.21,EC:3.4.21.77
Background
This gene is a member of the leukocyte immunoglobulin-like receptor (LIR) family, which is found in a gene cluster at chromosomal region 19q13.4. The encoded protein belongs to the subfamily B class of LIR receptors which contain two or four extracellular immunoglobulin domains, a transmembrane domain, and two to four cytoplasmic immunoreceptor tyrosine-based inhibitory motifs (ITIMs). The receptor is expressed on immune cells where it binds to MHC class I molecules on antigen-presenting cells and transduces a negative signal that inhibits stimulation of an immune response. It is thought to control inflammatory responses and cytotoxicity to help focus the immune response and limit autoreactivity. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008]

ProS1 Product List

No Data
You Have Viewed 0 Of 0 Results
  • 1

Can’t find what you need?

Submit your requirements and our technical
team will help.

Clinical Drug Information

English NameResearch CodeHighest Development StageCompanyIndicationClinical Trial
Tb161-RAD402Tb161-RAD402Phase 2 ClinicalRadiopharm Theranostics Ltd
Prostatic Neoplasms; Prostatic Neoplasms, Castration-Resistant
Details
GEA-408GEA-408Phase 2 ClinicalGenEros Biopharma Hangzhou Ltd
Prostatic Neoplasms
Details

Marketed Drug Information

English NameResearch CodeHighest Development StageCompanyFirst Brand NameFirst Approved CountryFirst IndicationFirst Approved CompanyFirst Approved DateIndicationClinical Trial
AfalaApprovedMateria Medica Holding Research And Production CompanyRussian FederationProstatic Neoplasms; ProstatitisMateria Medica Holding Research And Production Company2014-01-01
Prostatic Neoplasms; Prostatitis
Details